Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer
Condition: Neoplasms Intervention: Drug: VIP236 Sponsor: Vincerx Pharma, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials